(NYSE: MRK) has entered into an exclusive global license agreement with Hansoh Pharmaceutical Group Company Limited (HKEX: 3692) for the development and commercialization of HS-10270 , an investigational oral GLP-1 receptor agonist aimed at treating type 2 diabetes and obesity
How can authenticity be checked
However, some patients may prefer evening administration if they experience drowsiness or if morning nausea is problematic
Physicians must also be mindful of violations of the Medical Code of Ethics, which expressly prohibits the exercise of medicine as a commercial activity and the obtaining of advantages through prescriptions or referrals
Weight status and DSM-5 diagnoses of eating disorders in adolescents from the community
A Quick Note on GLP-1 Drugs (Ozempic, Victoza, and Others) You've probably heard about Ozempic, Wegovy, or Mounjaro